Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTSB | P07858 | 6/20 | 0.79 |
| ▸ | CTSK | P43235 | 4/20 | 0.79 |
| ▸ | CTSS | P25774 | 3/20 | 0.79 |
| ▸ | CTSH | P09668 | 2/20 | 0.79 |
| ▸ | CTSC | P53634 | 2/20 | 0.79 |
| ▸ | CTSL | P07711 | 7/20 | 0.68 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7359034 | 0.89 | CTSB (0.82) | CTSBCTSKCTSSCTSHCTSC | |
| SCHEMBL9889135 | 0.89 | CTSB (0.82) | CTSBCTSKCTSSCTSHCTSC | |
| SCHEMBL7856906 | 0.89 | CTSB (0.78) | CTSBCTSKCTSSCTSHCTSC | |
| SCHEMBL4447645 | 0.81 | CTSB (0.80) | CTSBCTSKCTSSCTSHCTSC | |
| SCHEMBL9891652 | 0.80 | CTSL (0.73) | CTSBCTSKCTSSCTSHCTSC | |
| SCHEMBL7353008 | 0.78 | CTSL (1.00) | CTSBCTSKCTSSCTSHCTSC | |
| SCHEMBL7352989 | 0.78 | CTSL (1.00) | CTSBCTSKCTSSCTSHCTSC | |
| SCHEMBL7352997 | 0.78 | CTSL (1.00) | CTSBCTSKCTSSCTSHCTSC | |
| SCHEMBL5417093 | 0.77 | CTSB (0.64) | CTSBCTSKCTSSCTSHCTSC | |
| SCHEMBL5417089 | 0.77 | CTSB (0.64) | CTSBCTSKCTSSCTSHCTSC |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210254056-A1 | IDENTIFICATION AND TARGETED MODULATION OF GENE SIGNALING NETWORKS | CAMP4 THERAPEUTICS CORPORATION | 2021-08-19 | — | — | US | disclosed |
| US-10877035-B2 | Advanced drug development and manufacturing | ICAGEN, LLC (US) | 2020-12-29 | — | — | US | disclosed |
| US-20190192691-A1 | REGULATED BIOCIRCUIT SYSTEMS | OBSIDIAN THERAPEUTICS, INC. | 2019-06-27 | — | — | US | disclosed |
| US-20150309021-A1 | Advanced Drug Development and Manufacturing | LOS ALAMOS NATIONAL SECURITY, LLC | 2015-10-29 | — | — | US | disclosed |
| EP-2511844-B1 | X-ray microscope | XRPRO SCIENCES INC (US) | 2015-08-12 | — | — | EP | disclosed |
| EP-2511844-A2 | Advanced drug development and manufacturing | Los Alamos National Security, LLC (US) | 2012-10-17 | — | — | EP | disclosed |
| EP-2084519-B1 | X-RAY FLUORESCENCE ANALYSIS METHOD | LOS ALAMOS NAT SECURITY LLC (US) | 2012-08-01 | — | — | EP | disclosed |
| US-20080220441-A1 | Advanced drug development and manufacturing | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2008-09-11 | — | — | US | disclosed |